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Platelets roll on vWF with biphasic velocity curves that align with wall shear 






























As force increases, GPIbα forms catch bonds and then slip bonds with WT 















Platelets roll on different vWF site densities with biphasic velocity curves that align with wall shear stress but not with wall shear rate. Platelets 
suspended in medium without or with 6% Ficoll were perfused through a flow chamber containing immobilized vWF in a range of flow rates. The 
flow chamber was coated with 100 μg/ml (A–C) or 440 μg/ml (C) vWF, resulting in the site densities shown in C. The rolling velocity is plotted 
versus the wall shear rate (A) or wall shear stress (B and C). Data are mean ± SD of 5 experiments.
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Unfixed and fixed platelets roll with biphasic velocity curves on WT A1, 





































As force increases, GPIbα forms catch bonds and then slip bonds with WT 
A1, but forms only slip bonds with R1306Q A1 and R1450E A1. (A, C, and D) 
Lifetimes of single GPIbα bonds with WT A1 (A), R1306Q A1 (C), or R1450E 
A1 (D) were measured by AFM. Data are mean ± SEM of several tens of 
measurements for each point. (B) Lifetimes of platelets or 1-μm-radius micro-
spheres bearing GPIbα transiently tethered to a flow chamber floor coated 
with 2 μg/ml WT A1 were measured. Data are mean ± SD of 3 experiments.
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Velocity curves of GPIbα-bearing microspheres rolling 
on WT or mutant A1 mimic those of platelets and align 















































Flowing platelets agglutinate with microspheres bearing R1306Q A1 or 









Unfixed and fixed platelets roll with biphasic velocity curves on WT A1, but with mono-
phasic velocity curves on R1306Q A1 and R1450E A1. Unfixed or fixed platelets in 
medium without or with Ficoll (to increase the viscosity by 2.6-fold) were perfused 
through a flow chamber containing immobilized WT A1 (A and B), R1306Q A1 (C 
and D), or R1450E A1 (E and F) in a range of flow rates. The rolling velocity is plotted 
versus the wall shear rate (A, C, and E) or wall shear stress (B, D, and F). Data are 
mean ± SD of 5 experiments.
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Velocity curves of GPIbα-bearing microspheres rolling on WT or mutant A1 mimic those of platelets and align when plotted versus tether force. 
GPIbα-bearing microspheres of 3- or 1-μm radius in medium with or without Ficoll (to increase the viscosity by 2.6-fold) were perfused through a 
flow chamber containing immobilized WT A1 (A–C), R1306Q A1 (D–F), or R1450E A1 (G–I) in a range of flow rates. The rolling velocity is plotted 
versus the wall shear rate (A, D, and G), wall shear stress (B, E, and H), or tether force (C, F, and I). Data are mean ± SD of 5 experiments.
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shear rate of 100 s–1. At this wall shear rate, the average tensile 





















A disintegrin and metalloproteinase with a thrombospondin type 1 
motif–13 reduces platelet agglutination with microspheres bearing R1450E 
































Structural explanations for why GPIbα forms catch bonds with WT A1 



















At the same shear rate, tensile force applied to bonds that link flowing 
platelets or microspheres is much lower than that applied to bonds that 
tether rolling platelets or microspheres. (A) Platelets or GPIbα-bearing 
microspheres of 1-μm radius were perfused through a flow chamber 
containing immobilized vWF or WT A1. The rolling velocity is plotted 
versus the wall shear rate. Data are mean ± SD of 5 experiments. (B) 
Schematic showing tensile forces (Ft) between spheres of equal and 
unequal size in a doublet as well as between a sphere and the wall 
under a simple shear field.
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Flowing platelets agglutinate with microspheres bearing R1306Q A1 or R1450E A1 (and R1450E A1A2A3), but not with microspheres bearing 
WT A1 (and A1A2A3), allowing ADAMTS-13 to cleave R1450E A1A2A3. Mixtures of platelets and Yellow-Green–labeled microspheres coated 
with WT A1 (A and D), R1306Q A1 (B), or R1450E A1 (C, E, and F) or with WT A1A2A3 or R1450E A1A2A3 domain triplet and then incubated 
with or without ADAMTS-13 (G) were perfused through a flow chamber coated with HSA in medium without or with 20 μg/ml anti-GPIbα mAb. 
After exiting the flow chamber, suspensions were fixed, stained with PE-conjugated anti-CD61 mAb, and analyzed by flow cytometry (A–C and 
G) or by fluorescence microscopy (D–F). (A–C) Flow cytometry of samples gated for single green particles. The red fluorescence histograms 
measured without (red curve) or with (blue curve) anti-GPIbα mAb are compared. The percentage of particles in the anti-GPIbα mAb curve 
with significant increase in fluorescence intensity relative to the curve without this mAb is indicated for 1 experiment; the mean ± SD of 3 or 4 
experiments is shown in Results. (D–F) Representative fluorescence micrographs of mixtures of platelets and microspheres bearing WT A1 
(D), R1450E A1 (E), or R1450E A1 plus anti-GPIbα mAb (F). Scale bar: 10 μm. (G) Percentage (mean ± SD of 3 experiments) of single green 
particles with red fluorescence, as measured by flow cytometry after the samples prepared as indicated were subjected to different shears. Inset 
shows the WT groups subjected to shear rate of 2,000 s–1 on a smaller scale. *P < 0.01, Student’s t test.
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Structural model for WT A1 catch bonds (see Results 
for details). (A–E) Sequential snapshots of SMD-
simulated structures showing pathways of the sliding-
rebinding mechanism. Mauve, A1; gray, GPIbαN; red 
spheres, D1269; blue spheres, R1306; green spheres, 
R1450; blue β-strands, β-switch; red β-strands, cen-
tral β-sheet of A1; red sticks, E14; blue sticks, R1334. 
The equilibrated structure (A) was used as a starting 
point of SMD simulations to generate the simulated 
structures in B–E. (F) Overlay of the structures in A 
(colors same as in A) and D (green, A1; cyan, GPIbα), 
showing the rotation of A1 and sliding of the GPIbα 
β-finger over A1. (G) Sliding-rebinding mechanism for 
GPIb/vWF A1 catch bonds.
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Structural models for elimination of 
catch bonds by A1 mutations (see 
Results for details). (A) Comparison 
of the mutant structure of GPIbαN 
(gray) liganded with A1 (pink) with the 
structure of the WT complex (cyan). 
The mutant structure includes substi-
tutions in both GPIbαN (M239V) and 
A1 (R1306Q). The conformational 
changes observed in the 1308–1314 
loop of A1 are highlighted in blue in 
the WT and red in the mutant struc-
ture (boxed region). The A1 residue 
R1334 in the WT structure (blue 
sticks) is tilted leftward in the mutant 
structure (red sticks), which reduces 
its distance to the GPIbα residue 
E14 in the mutant structure (orange 
sticks), but not in the WT structure 
(blue sticks). (B) After energy minimi-
zation, a salt bridge formed between 
A1 R1334 and GPIbα E14 in the 
mutant structure, which was held 
during most of the 20-ns equilibration 
simulations. This salt bridge did not 
form in the WT structure (see Figure 
7). (C) Model for the R1306Q muta-
tion to eliminate catch bonds. (D) 
Alternative model for the R1450E 
mutation to eliminate catch bonds.
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